Research-use disclaimer

For laboratory and research use only — not for human consumption.

All content on metabolicpeptides.co.uk is provided for educational and scientific reference. The site accepts sponsored placement from a disclosed research-peptide supplier partner; the sponsored content is clearly labelled and appears in dedicated ad units. Editorial content itself is independent — sponsorship does not influence which trials, molecules or safety signals are covered. We do not prescribe, sell, compound or ship medicines. Investigational and research-only peptides are not licensed by the MHRA, EMA or FDA for human therapeutic use and must not be used outside an appropriately authorised, ethically approved research setting. Prescription-only medicines should only be accessed through a qualified UK prescriber following appropriate clinical assessment. Nothing here constitutes medical, dosing, sourcing or self-experimentation advice.

Scope of content

All information on metabolicpeptides.co.uk is intended for educational, scientific and research purposes only. The content discusses research peptides that are either (a) MHRA-licensed prescription medicines used within their licensed indications, or (b) research compounds supplied for laboratory and analytical use that are NOT licensed for human therapeutic application by the MHRA, EMA, FDA or any other regulator.

Not medical advice

Nothing on this site constitutes medical advice, diagnosis, treatment or prescription. We do not have a doctor-patient relationship with any reader and cannot answer individual health questions. Always consult a qualified medical professional licensed in your jurisdiction before making any decision affecting your health.

Not a vendor

We do not sell, ship, compound, prescribe or otherwise supply peptides. Mentions of third-party suppliers exist solely to direct UK researchers seeking laboratory-grade reference material with batch-level certificates of analysis to publicly trading suppliers. We do not warrant any third-party supplier; users are responsible for their own due diligence.

No human-use protocols

Any dosage range mentioned on this site is a theoretical extrapolation from published research literature, included for academic completeness only. It is not a protocol for human use. Off-label, unsupervised or recreational use of any research peptide carries significant risk including infection, anaphylaxis, contamination from non-pharmaceutical material, and unknown long-term effects.

UK regulatory context

In the United Kingdom, only compounds licensed by the MHRA may be prescribed for human use, and only by an appropriately registered healthcare professional. Tirzepatide (Mounjaro), semaglutide (Ozempic / Wegovy / Rybelsus) and liraglutide (Saxenda / Victoza) are MHRA-licensed for specified indications and must be obtained through the licensed supply chain. All other compounds discussed here are research peptides only.

Liability

Metabolic Peptides, its editors and contributors accept no liability for any loss, injury or adverse outcome arising from use, misuse, or reliance on the information provided on this site. Users access this content at their own risk.